-
Sponsored by Baciu PartnersBaciu Partners talks about extends mediation procedure before the office for all inter-partes disputes
-
Sponsored by HANOL ClassHankyul IP & LawMin Son of Hanol IP & Law summarises a Korean Supreme Court ruling on when consumer surveys are admissible in trademark litigation and outlines key takeaways for ensuring survey credibility and evidentiary value
-
Sponsored by Licks AttorneysLicks Attorneys talks about global patent strategies
-
Sponsored by SS Rana & CoSS Rana & Co talk about the music licensing battle
-
Sponsored by Nestor Nestor Diculescu Kingston Petersen (NNDKP)Nestor Nestor Diculescu Kingston Petersen (NNDKP) talks about the Romanian copyright law perspective
-
Sponsored by Gün + PartnersUğur Aktekin, Selin Bilik, and Bilge Ayperi Kemer of Gün + Partners examine a ruling confirming that trademark distinctiveness and reputation can prove bad faith under Turkish law
-
Sponsored by CASThe emerging trends and strategic approaches in intellectual property search and analytics are outlined in a CAS article that suggests how chemical industry stakeholders can strengthen patent programmes, empower R&D teams, and gain competitive insight
-
Sponsored by MaiwaldSenior Maiwald lawyers outline the strategy behind the firm’s recognition as EPO Proceedings Firm of the Year at the Managing IP EMEA Awards 2025 and discuss key developments in the European intellectual property space
-
Sponsored by Bugnion SpAVieri Canepele of Bugnion SpA examines a landmark Italian Supreme Court ruling on whether a patent co-owner may exploit a jointly owned invention without consent from fellow rights holders
-
Sponsored by Liu Shen & AssociatesGuanyang Yao of Liu, Shen & Associates reviews several Chinese court rulings on standard-essential patent disputes, including Panasonic v Oppo, and the growing judicial focus on mediation and comparable licences over top-down rate setting
-
Sponsored by Wanhuida Intellectual PropertyWu Xiaohui of Wanhuida Intellectual Property examines how a recent CNIPA decision reinforces the need for a holistic inventive step assessment when evaluating pharmaceutical combination formulations involving active ingredients that are chemically reactive
-
Sponsored by MaiwaldAnnelie Wünsche of Maiwald Intellectual Property summarises the EU’s proposed update to the supplementary protection certificate system for medicinal products, highlighting key procedural shifts, the role of the EUIPO, and ongoing debate over the most suitable examining authority